Lactobacillus plantarum MG4229 for blood glucose control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for diabetes mellitus, particularly type 2, face challenges with side effects and resistance to drugs, and there is a need for natural products with antioxidant properties to address hyperlipidemia, diabetes, and aging-related issues.

Innovation Solution

A Lactobacillus plantarum MG4229 strain with high blood glucose lowering activity and antioxidant properties, exhibiting excellent α-glucosidase inhibitory, α-amylase inhibitory, and insulin resistance improvement effects, is identified and developed for use in compositions to manage diabetes and provide antioxidant benefits.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If drug therapy is used to control blood glucose level, then blood glucose control is achieved, but side effects and patient chemical resistance occur

Engineering Contradiction:
Improveblood glucose controlVSAvoidside effects and chemical resistance
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses probiotic bacteria (Lactobacillus plantarum MG4229) as a biological agent that can be safely administered without causing harmful side effects or chemical resistance, replacing conventional drugs that have these adverse effects

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The probiotic strain acts as an intermediary substance that modulates the body's metabolic processes and immune response to achieve blood glucose control without direct pharmacological intervention, thereby avoiding drug-related side effects and resistance

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If conventional diabetes treatment is used, then blood glucose level is controlled, but quality of life is reduced due to side effects

Engineering Contradiction:
Improveblood glucose controlVSAvoidquality of life
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The probiotic strain serves as a safe, non-harmful biological agent that improves blood glucose control without the quality-of-life reducing side effects associated with conventional diabetes medications

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The probiotic strain utilizes the body's own immune system and metabolic processes to achieve blood glucose control, rather than imposing external pharmacological agents that interfere with normal physiological functions and reduce quality of life

Inventive Principle:
Principle #25Self-service

3Object-affected harmful factors

If natural products with antioxidant properties are used, then antioxidant effects are achieved, but effectiveness in managing diabetes is insufficient

Engineering Contradiction:
Improveoxidative stressVSAvoiddiabetes management
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The probiotic strain Lactobacillus plantarum MG4229 performs multiple functions simultaneously: it provides antioxidant effects, lowers blood glucose levels, improves insulin sensitivity, and modulates immune response, making it a comprehensive diabetes management solution rather than a single-function supplement

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The probiotic strain acts as a composite biological agent that combines multiple active components (bacterial cells, metabolites, and modulatory proteins) to achieve synergistic effects in antioxidant activity and diabetes management, surpassing the effectiveness of single-component natural products

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Lactobacillus plantarum MG4229 strain effectively lowers blood glucose levels, improves insulin resistance, and exhibits strong antioxidant activity, making it suitable for preventing or treating diabetes mellitus and promoting overall health, with potential applications in health functional foods and pharmaceutical compositions.

Implementation Method 1

exhibiting excellent α-glucosidase inhibitory, α-amylase inhibitory, and insulin resistance improvement effects

Methodology Applied
Scientific EffectEnzyme inhibition: Enzyme

Implementation Method 2

Lactobacillus plantarum MG4229 strain with high blood glucose lowering activity and antioxidant properties

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentUS11738057B2<i>Lactobacillus </i>having blood glucose lowering effect and antioxidant effect
Publication Date: 2023.08.29 MEDIOGEN
  • US11738057B2 patent drawing
  • US11738057B2 patent drawing

AI summary

Disclosed is a Lactobacillus strain having a blood glucose lowering effect and an antioxidant effect, a culture medium of the strain, and a cell-free supernatant of the strain. Further, a composition for lowering a blood glucose level contains the same. A composition having an antioxidant ability contains the same. The Lactobacillus plantarum MG4229 strain according to the present disclosure has excellent blood glucose lowering activity and antioxidant activity, and has excellent acid tolerance, bile tolerance, auto-aggregation, and adhesion to epithelial cells, and thus is suitable for probiotics, and thus may be used in various ways as a composition for preventing or treating diabetes mellitus or a composition having antioxidant ability.